Verano Holdings Corp ( VRNO) - Key Metrics
VRNO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.98 | -$0.18 | $0.41 | $0.25 |
| 2026Q1 | $2.82 | -$0.24 | $0.25 | $0.05 |
| 2025Q4 | $3.07 | -$2.56 | $0.19 | $0.06 |
| 2025Q3 | $2.77 | -$0.60 | $0.36 | $0.26 |
| 2025Q2 | $2.81 | -$0.27 | $0.15 | $0.01 |
VRNO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.07 |
| 2026Q1 | 0% | -5.78 |
| 2025Q4 | 0% | -0.62 |
| 2025Q3 | 0% | -2.88 |
| 2025Q2 | 0% | -2.31 |
VRNO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3.82% | 0% |
| 2026Q1 | 0.89% | 0% |
| 2025Q4 | 0.97% | 0% |
| 2025Q3 | 3.82% | 0% |
| 2025Q2 | 0.24% | 0% |
VRNO
Price: $5.27
52 week price:
Earnings Per Share: -0.99 USD
P/E Ratio: -1.08
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 388.8 million